意见反馈

VOLUNTARY ANNOUNCEMENT - PRINCIPAL OPERATING DATA AND INDICATORS FORTHE SIX MONTHS ENDED JUNE 30, 2024 ANDTHE SECOND QUARTER 2024

2024-07-03 00:00:00

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.VOLUNTARY ANNOUNCEMENT PRINCIPAL OPERATING DATA AND INDICATORS FOR THE SIX MONTHS ENDED JUNE 30 2024 AND THE SECOND QUARTER 2024 This is a voluntary announcement made by Wenzhou Kangning Hospital Co. Ltd. (the “Company”) to keep the shareholders of the Company and potential investors informed of the latest business developments of the Company and its subsidiaries (the “Group”).The table below sets forth the relevant operating data and indicators of the Group’s owned hospitals by inpatients and outpatients for the six months ended June 30 2024 with comparative figures for the six months ended June 30 2023: For the six months ended June 30 Year-on-year 2024 2023 changes Inpatients Number of inpatient bed-days 1852397 1607422 15.2% Average inpatient spending per bed-day on treatment and general healthcare services (RMB) 316 344 -8.1% Average inpatient spending per bed-day on pharmaceutical sales (RMB) 49 52 -5.8% Total average inpatient spending per bed-day (RMB) (1) 365 396 -7.8% Outpatients Number of outpatient visits 243108 250648 -3.0% Average outpatient spending per visit on treatment and general healthcare services (RMB) 129 134 -3.7% Average outpatient spending per visit on pharmaceutical sales (RMB) 313 291 7.6% Total average outpatient spending per visit (RMB) 442 425 4.0% 1The table below sets forth the relevant operating data and indicators of the Group’s owned hospitals by inpatients and outpatients for the three months (the second quarter) from April 1 2024 to June 30 2024 with comparative figures of the same period in 2023: Three months from April 1 to June 30 Year-on-year 2024 2023 changes Inpatients Number of inpatient bed-days 955373 837673 14.1% Average inpatient spending per bed-day on treatment and general healthcare services (RMB) 322 338 -4.7% Average inpatient spending per bed-day on pharmaceutical sales (RMB) 48 51 -5.9% Total average inpatient spending per bed-day (RMB) (1) 370 389 -4.9% Outpatients Number of outpatient visits 122168 125977 -3.0% Average outpatient spending per visit on treatment and general healthcare services (RMB) 139 142 -2.1% Average outpatient spending per visit on pharmaceutical sales (RMB) 298 303 -1.7% Total average outpatient spending per visit (RMB) 437 445 -1.8% Note: 1. The above total average inpatient spending per bed-day is determined based on the Company’s bills for services provided to patients without taking into account differences with medical insurance settlements and the Company’s income deduction for some medical expenses that may not be received.The above operating data and indicators are based on the Company’s records and have not been audited or reviewed by the Company’s auditors. The operating data and indicators may be different from those disclosed in relevant periodical reports. The operating data and indicators disclosed in relevant periodical reports shall prevail if there is any discrepancy. 2Shareholders and potential investors of the Company are reminded to rationally deal with any information not officially released by the Company and Shareholders and potential investors of the Company should exercise caution when dealing in the shares of the Company.By order of the Board Wenzhou Kangning Hospital Co. Ltd.GUAN Weili Chairman Zhejiang the PRC July 3 2024 As at the date of this announcement the Company’s executive directors are Mr. GUAN Weili Ms.WANG Lianyue and Mr. WANG Jian; the non-executive directors are Mr. QIN Hao and Mr. LI Changhao; and the independent non-executive directors are Ms. ZHONG Wentang Ms. JIN Ling and Mr. CHAN Sai Keung Hugo. 3